Evidence mapPaperPMID 40244288Full record

ArticleInternational journal of molecular sciences2025

Fecal miRNA Profiling of Yorkshire Terrier Enteropathy.

Dana Mashaal, Magdalena Putzer, Patricia Freund, Hadi Shabanloo, Barbara Pratscher, Georg Csukovich, Katrin Spirk, Alexandro Rodríguez-Rojas, Iwan A Burgener

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Dana MashaalDepartment for Small Animal and Horses, Clinic for Small Animals, University of Veterinary Medicine, 1210 Vienna, Austria.
Magdalena PutzerDepartment for Small Animal and Horses, Clinic for Small Animals, University of Veterinary Medicine, 1210 Vienna, Austria.
Patricia FreundDepartment for Small Animal and Horses, Clinic for Small Animals, University of Veterinary Medicine, 1210 Vienna, Austria.
Hadi ShabanlooDepartment for Small Animal and Horses, Clinic for Small Animals, University of Veterinary Medicine, 1210 Vienna, Austria.
Barbara PratscherDepartment for Small Animal and Horses, Clinic for Small Animals, University of Veterinary Medicine, 1210 Vienna, Austria.ORCID 0000-0001-5291-1365
Georg CsukovichDepartment for Small Animal and Horses, Clinic for Small Animals, University of Veterinary Medicine, 1210 Vienna, Austria.ORCID 0000-0001-5615-666X
Katrin SpirkDepartment for Small Animal and Horses, Clinic for Small Animals, University of Veterinary Medicine, 1210 Vienna, Austria.
Alexandro Rodríguez-RojasDepartment for Small Animal and Horses, Clinic for Small Animals, University of Veterinary Medicine, 1210 Vienna, Austria.ORCID 0000-0002-4119-8127
Iwan A BurgenerDepartment for Small Animal and Horses, Clinic for Small Animals, University of Veterinary Medicine, 1210 Vienna, Austria.ORCID 0000-0002-8516-0040

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

MicroRNAs (miRNAs) are small non-coding RNAs involved in gene regulation and are potential biomarkers for several diseases, including canine enteropathies. While metabolite profiling and microbiome in canine enteropathies have been previously explored, data on miRNA expression remain limited. This study aimed to profile miRNA expression in Yorkshire Terrier canine enteropathy using Illumina sequencing and quantitative PCR (qPCR) to compare miRNA levels between sick and healthy dogs from fecal samples. Despite the hypothesis that disease-related alterations in miRNA levels would differentiate sick dogs from controls, no significant differences were observed between the groups in either sequencing or qPCR analyses. These findings suggest that miRNA profiles may not vary significantly in the context of Yorkshire Terrier enteropathy and indicate that other molecular or metabolomic markers may be more indicative of disease state. This study also indicates that fecal samples may not be an ideal sample type for miRNA profiling. This study contributes to the understanding of molecular signatures in canine enteropathies and provides a basis for further research into alternative biomarkers for diagnosis and monitoring.

Indexed as

Dog DiseasesFecesIntestinal DiseasesMicroRNAsAnimalsBiomarkersDogsFemaleGene Expression ProfilingHigh-Throughput Nucleotide SequencingMaleBiomarkersMicroRNAsbiomarkercanine IBDchronic enteropathyIBDinflammatory bowel diseasesmiRNA

Identifiers

PMID40244288
PMCPMC11989276

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.